CLINICAL_TRIALS
trial_result
· 2020-03-10
Clinical Trial Update: Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients [Phase 2]
Summary
Phase 2 trial of Zilucoplan (RA101495) for Paroxysmal Nocturnal Hemoglobinuria has completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ra Pharmaceuticals | Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH) | Phase 2 | Status: COMPLETED | Results posted: 2020-03-10